R Kubin

928 total citations
13 papers, 694 citations indexed

About

R Kubin is a scholar working on Epidemiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R Kubin has authored 13 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Pharmacology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R Kubin's work include Pneumonia and Respiratory Infections (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antibiotic Resistance in Bacteria (4 papers). R Kubin is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antibiotic Resistance in Bacteria (4 papers). R Kubin collaborates with scholars based in Germany, United Kingdom and United States. R Kubin's co-authors include Shurjeel Choudhri, Robert C. Owens, Peter Ball, Ralf Stahlmann, I Duprat-Lomon, G. Höffken, Antoní Torres, Harry P. Bassaris, P Léophonte and Ad J.M. Schreurs and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and European Respiratory Journal.

In The Last Decade

R Kubin

13 papers receiving 654 citations

Peers

R Kubin
Pierre Arvis France
P. Zück France
Anna Ochoa de Echagüen Spain
Marc Garnier France
Stéphane Paulus United Kingdom
L. Å. Burman Sweden
Barbara A. Wiesinger United States
K Corkery United States
J. P. Bédos France
José Manuel Pereira Portugal
Pierre Arvis France
R Kubin
Citations per year, relative to R Kubin R Kubin (= 1×) peers Pierre Arvis

Countries citing papers authored by R Kubin

Since Specialization
Citations

This map shows the geographic impact of R Kubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Kubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Kubin more than expected).

Fields of papers citing papers by R Kubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Kubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Kubin. The network helps show where R Kubin may publish in the future.

Co-authorship network of co-authors of R Kubin

This figure shows the co-authorship network connecting the top 25 collaborators of R Kubin. A scholar is included among the top collaborators of R Kubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Kubin. R Kubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gavin, James R., R Kubin, Shurjeel Choudhri, et al.. (2004). Moxifloxacin and Glucose Homeostasis. Drug Safety. 27(9). 671–686. 32 indexed citations
2.
Ball, Peter, Ralf Stahlmann, R Kubin, Shurjeel Choudhri, & Robert C. Owens. (2004). Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies. Clinical Therapeutics. 26(7). 940–950. 87 indexed citations
3.
Drummond, Michael, Margaret Hux, J Chancellor, et al.. (2003). An Economic Evaluation of Sequential IV/po Moxifloxacin Therapy Compared to IV/po Co-amoxiclav With or Without Clarithromycin in the Treatment of Community-Acquired Pneumonia*. CHEST Journal. 124(2). 526–535. 45 indexed citations
4.
Torres, Antoni, et al.. (2003). Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. European Respiratory Journal. 21(1). 135–143. 70 indexed citations
5.
6.
Miravitlles, Marc, et al.. (2001). THE EFFICACY OF MOXIFLOXACIN IN ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS: A SPANISH PHYSICIAN AND PATIENT EXPERIENCE. International Journal of Clinical Practice. 55(7). 437–441. 29 indexed citations
7.
Lorenz, J., et al.. (2001). Treatment Outcomes in Acute Exacerbations of Chronic Bronchitis: Comparison of Macrolides and Moxifloxacin from the Patient Perspective. Journal of International Medical Research. 29(2). 74–86. 29 indexed citations
8.
Møller, Marianne, et al.. (2001). Clinical Experience in Germany of Treating Community-Acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin. Journal of International Medical Research. 29(2). 51–60. 30 indexed citations
9.
10.
Wilson, Robert J., R Kubin, Karl-Matthias Deppermann, et al.. (1999). Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 44(4). 501–513. 138 indexed citations
11.
Redmond, A. O. B., et al.. (1998). Oral Ciprofloxacin in the Treatment of Pseudomonas Exacerbations of Paediatric Cystic Fibrosis: Clinical Efficacy and Safety Evaluation Using Magnetic Resonance Image Scanning. Journal of International Medical Research. 26(6). 304–312. 19 indexed citations
12.
Kubin, R. (1993). Safety and efficacy of ciprofloxacin in paediatric patients — Review. Infection. 21(6). 413–421. 57 indexed citations
13.
Kubin, R, et al.. (1992). Intratracheal Application of Sephadex in Rats Leads to Massive Pulmonary Eosinophilia without Bronchial Hyperreactivity to Acetylcholine. International Archives of Allergy and Immunology. 98(3). 266–272. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Arvis Breakdown of academic impact, for papers by P. Zück Breakdown of academic impact, for papers by Anna Ochoa de Echagüen Breakdown of academic impact, for papers by Marc Garnier Breakdown of academic impact, for papers by Stéphane Paulus Breakdown of academic impact, for papers by L. Å. Burman Breakdown of academic impact, for papers by Barbara A. Wiesinger Breakdown of academic impact, for papers by K Corkery Breakdown of academic impact, for papers by J. P. Bédos Breakdown of academic impact, for papers by José Manuel Pereira
Rankless by CCL
2026